207 related articles for article (PubMed ID: 36194039)
1. TAC score better predicts survival than the BCLC following resection of hepatocellular carcinoma.
Lima HA; Endo Y; Moazzam Z; Alaimo L; Shaikh C; Munir MM; Resende V; Guglielmi A; Marques HP; Cauchy F; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Endo I; Kitago M; Shen F; Pawlik TM
J Surg Oncol; 2023 Mar; 127(3):374-384. PubMed ID: 36194039
[TBL] [Abstract][Full Text] [Related]
2. Tumor Burden Score and Serum Alpha-fetoprotein Subclassify Intermediate-Stage Hepatocellular Carcinoma.
Lima HA; Endo Y; Alaimo L; Moazzam Z; Munir MM; Shaikh C; Resende V; Guglielmi A; Marques HP; Cauchy F; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Hugh T; Endo I; Kitago M; Shen F; Pawlik TM
J Gastrointest Surg; 2022 Dec; 26(12):2512-2521. PubMed ID: 36171471
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular carcinoma tumour burden score to stratify prognosis after resection.
Tsilimigras DI; Moris D; Hyer JM; Bagante F; Sahara K; Moro A; Paredes AZ; Mehta R; Ratti F; Marques HP; Silva S; Soubrane O; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Endo I; Sasaki K; Rodarte AI; Aucejo FN; Pawlik TM
Br J Surg; 2020 Jun; 107(7):854-864. PubMed ID: 32057105
[TBL] [Abstract][Full Text] [Related]
4. Tumor burden score-AFP-albumin-bilirubin grade score predicts the survival of patients with hepatocellular carcinoma after liver resection.
Qiu ZC; Li C; Zhang Y; Xie F; Yu Y; Leng SS; Chen TH; Wen TF
Langenbecks Arch Surg; 2023 Jun; 408(1):250. PubMed ID: 37382724
[TBL] [Abstract][Full Text] [Related]
5. Prediction of tumor recurrence by α-fetoprotein model after curative resection for hepatocellular carcinoma.
Ding HF; Zhang XF; Bagante F; Ratti F; Marques HP; Soubrane O; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Lv Y; Pawlik TM
Eur J Surg Oncol; 2021 Mar; 47(3 Pt B):660-666. PubMed ID: 33082065
[TBL] [Abstract][Full Text] [Related]
6. Utilizing Machine Learning for Pre- and Postoperative Assessment of Patients Undergoing Resection for BCLC-0, A and B Hepatocellular Carcinoma: Implications for Resection Beyond the BCLC Guidelines.
Tsilimigras DI; Mehta R; Moris D; Sahara K; Bagante F; Paredes AZ; Farooq A; Ratti F; Marques HP; Silva S; Soubrane O; Lam V; Poultsides GA; Popescu I; Grigorie R; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Endo I; Pawlik TM
Ann Surg Oncol; 2020 Mar; 27(3):866-874. PubMed ID: 31696396
[TBL] [Abstract][Full Text] [Related]
7. External validation of a simplified BCLC staging system for early hepatocellular carcinoma.
Santambrogio R; Salceda J; Costa M; Kluger MD; Barabino M; Laurent A; Opocher E; Azoulay D; Cherqui D
Eur J Surg Oncol; 2013 Aug; 39(8):850-7. PubMed ID: 23726257
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of Serum α-Fetoprotein Level as an Important Characteristic of Tumor Biology for Patients Undergoing Liver Resection of Early-Stage Hepatocellular Carcinoma (BCLC Stage 0/A): A Large Multicenter Analysis.
Yao LQ; Fan ZQ; Wang MD; Diao YK; Chen TH; Zeng YY; Chen Z; Wang XM; Zhou YH; Li J; Fan XP; Liang YJ; Li C; Shen F; Lv GY; Yang T
Ann Surg Oncol; 2024 Feb; 31(2):1219-1231. PubMed ID: 37925654
[TBL] [Abstract][Full Text] [Related]
9. Ascites and alpha-fetoprotein improve prognostic performance of Barcelona Clinic Liver Cancer staging.
Gomaa AI; Al-Khatib A; Abdel-Razek W; Hashim MS; Waked I
World J Gastroenterol; 2015 May; 21(18):5654-62. PubMed ID: 25987792
[TBL] [Abstract][Full Text] [Related]
10. Radiographic tumor burden score is useful for stratifying the overall survival of hepatocellular carcinoma patients undergoing resection at different Barcelona Clinic Liver Cancer stages.
Li WF; Liu YW; Wang CC; Yong CC; Lin CC; Yen YH
Langenbecks Arch Surg; 2023 May; 408(1):169. PubMed ID: 37121930
[TBL] [Abstract][Full Text] [Related]
11. Validation of an alpha-fetoprotein model to predict recurrence after liver resection for hepatocellular carcinoma.
Li WF; Yen YH; Liu YW; Wang CC; Yong CC; Lin CC; Cheng YF; Wang JH
Updates Surg; 2022 Aug; 74(4):1345-1352. PubMed ID: 34374920
[TBL] [Abstract][Full Text] [Related]
12. TBS-Based Preoperative Score to Predict Non-transplantable Recurrence and Identify Candidates for Upfront Resection Versus Transplantation for Hepatocellular Carcinoma.
Lima HA; Moazzam Z; Endo Y; Alaimo L; Shaikh C; Munir MM; Resende V; Guglielmi A; Marques HP; Cauchy F; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Hugh T; Endo I; Kitago M; Shen F; Pawlik TM
Ann Surg Oncol; 2023 Jun; 30(6):3363-3373. PubMed ID: 36820934
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of the OSASH score to predict overall survival of hepatocellular carcinoma after surgical resection: a dual-institutional study.
Wei H; Fu F; Jiang H; Wu Y; Qin Y; Wei H; Yang T; Wang M; Song B
Eur Radiol; 2023 Nov; 33(11):7631-7645. PubMed ID: 37191923
[TBL] [Abstract][Full Text] [Related]
14. Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification.
Kamiyama T; Orimo T; Wakayama K; Shimada S; Nagatsu A; Yokoo H; Kamachi H; Yamashita K; Shimamura T; Taketomi A
World J Surg Oncol; 2017 Aug; 15(1):156. PubMed ID: 28830473
[TBL] [Abstract][Full Text] [Related]
15. Recurrence Patterns and Outcomes after Resection of Hepatocellular Carcinoma within and beyond the Barcelona Clinic Liver Cancer Criteria.
Tsilimigras DI; Bagante F; Moris D; Hyer JM; Sahara K; Paredes AZ; Mehta R; Ratti F; Marques HP; Soubrane O; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Endo I; Pawlik TM
Ann Surg Oncol; 2020 Jul; 27(7):2321-2331. PubMed ID: 32285278
[TBL] [Abstract][Full Text] [Related]
16. Application of hazard functions to investigate recurrence after curative-intent resection for hepatocellular carcinoma.
Lima HA; Alaimo L; Brown ZJ; Endo Y; Moazzam Z; Tsilimigras DI; Shaikh C; Resende V; Guglielmi A; Ratti F; Aldrighetti L; Marques HP; Soubrane O; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Hugh T; Endo I; Shen F; Pawlik TM
HPB (Oxford); 2023 Feb; 25(2):260-268. PubMed ID: 36470717
[TBL] [Abstract][Full Text] [Related]
17. Hepatic resection for "BCLC stage A" hepatocellular carcinoma. The prognostic role of alpha-fetoprotein.
Santambrogio R; Opocher E; Costa M; Barabino M; Zuin M; Bertolini E; De Filippi F; Bruno S
Ann Surg Oncol; 2012 Feb; 19(2):426-34. PubMed ID: 21732145
[TBL] [Abstract][Full Text] [Related]
18. The value of the Barcelona Clinic Liver Cancer and alpha-fetoprotein in the prognosis of hepatocellular carcinoma.
Gómez-Rodríguez R; Romero-Gutiérrez M; Artaza-Varasa T; González-Frutos C; Ciampi-Dopazo JJ; de-la-Cruz-Pérez G; Sánchez-Ruano JJ
Rev Esp Enferm Dig; 2012 Jun; 104(6):298-304. PubMed ID: 22738699
[TBL] [Abstract][Full Text] [Related]
19. Prognosis After Resection of Barcelona Clinic Liver Cancer (BCLC) Stage 0, A, and B Hepatocellular Carcinoma: A Comprehensive Assessment of the Current BCLC Classification.
Tsilimigras DI; Bagante F; Sahara K; Moris D; Hyer JM; Wu L; Ratti F; Marques HP; Soubrane O; Paredes AZ; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Endo I; Pawlik TM
Ann Surg Oncol; 2019 Oct; 26(11):3693-3700. PubMed ID: 31267302
[TBL] [Abstract][Full Text] [Related]
20. Surgical and oncological outcomes of hepatic resection for BCLC-B hepatocellular carcinoma: a retrospective multicenter analysis among 474 consecutive cases.
Di Sandro S; Centonze L; Pinotti E; Lauterio A; De Carlis R; Romano F; Gianotti L; De Carlis L;
Updates Surg; 2019 Jun; 71(2):285-293. PubMed ID: 30941704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
